Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, et al
This fact check was reviewed by a member of Rapplers research team and a senior editor
Minor side effects & safety profile While AOD 9604 appears to have a favorable tolerability profile in early trials, there are still relevant caution points: Reported/mild side-effects Injection-site reactions: redness, swelling, itching, mild pain
But how quickly you respond depends on several factors: Type and severity of injury Route of administration (oral vs injection) Overall metabolic health and inflammation load Whether other therapies (like physical therapy or PRP) are in place What to expect in the first 2 weeks Localized pain may ease (if using subcutaneous injection near injury site) Mobility may improve as inflammation subsides GI symptoms may reduce if using oral BPC-157 consistently on an empty stomach How to prepare for best results Use a consistent protocol same time of day, same dose Inject near the injury site if healing musculoskeletal tissue Avoid alcohol and NSAIDs , which may interfere with gut repair or healing cascades Track symptoms daily to help your provider assess response Peptides dont work like instant relief medications
10.1016/S1474-4422(09)70014-6 106 WuB.TengH.ZhangL.LiH.LiJ.WangL.et al (2015)
